Oxford Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-869
Closed -$352K 742
2025
Q2
$352K Sell
869
-233
-21% -$97.4K 0.12% 281
2025
Q1
$548K Buy
+1,102
New +$597K 0.25% 115
2024
Q3
Sell
-617
Closed -$341K 449
2024
Q2
$341K Buy
+617
New +$353K 0.33% 112
2024
Q1
Sell
-503
Closed -$267K 361
2023
Q4
$267K Buy
+503
New +$243K 0.4% 105
2019
Q4
Sell
-25,393
Closed -$7.4M 2090
2019
Q3
$7.4M Buy
25,393
+22,595
+808% +$6.47M 0.18% 150
2019
Q2
$822K Sell
2,798
-6,708
-71% -$1.85M 0.02% 1066
2019
Q1
$2.6M Sell
9,506
-32,550
-77% -$8.1M 0.06% 452
2018
Q4
$9.41M Buy
+42,056
New +$9.87M 0.24% 79
2018
Q3
Sell
-1,006
Closed -$208K 1922
2018
Q2
$208K Buy
+1,006
New +$214K ﹤0.01% 1583

Other funds holding TMO

Oxford Asset Management's TMO Position: Q3 2025 in Review

Oxford Asset Management sold out of Thermo Fisher Scientific (TMO) in Q3 2025, closing a stake of 869 shares — an estimated $352K sold.

Oxford Asset Management first reported a position in TMO in Q2 2018 and held it in 9 quarters. The position peaked at $9.41M in Q4 2018. 2,508 funds tracked by Wall St. Rank hold TMO as of Q3 2025.

  • Oxford Asset Management reported no remaining Thermo Fisher Scientific position as of Q3 2025 after selling out during the quarter.
  • Oxford Asset Management sold 869 Thermo Fisher Scientific shares in Q3 2025, an estimated $352K.
  • Oxford Asset Management first reported a position in Thermo Fisher Scientific in Q2 2018 and held it in 9 quarters.
  • Oxford Asset Management's Thermo Fisher Scientific position peaked at $9.41M in Q4 2018.
  • 2,508 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2025.

Based on Oxford Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.